ConductScience.org, home

Paper41004053

New Therapeutic Modalities in Prion Diseases.

Pettinari A and 2 others. Subcell Biochem, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. New Therapeutic Modalities in Prion Diseases. Papers, record 41004053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004053

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New Therapeutic Modalities in Prion Diseases.
PubMed
Journal
Subcell Biochem
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-03-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pettinari AAlberto
2Uliassi EElisa
3Bolognesi MLMaria Laura

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prion DiseasesMajor topic
Prion ProteinsMajor topic
Humans
Small Molecule Libraries
Genetic Therapy

References95

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129242534The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions.Sci Rep2017https://conductscience.org/library/papers/29242534PubMed
229972753Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.N Engl J Med2018https://conductscience.org/library/papers/29972753PubMed
319182537Autophagy induction by trehalose counteracts cellular prion infection.Autophagy2009https://conductscience.org/library/papers/19182537PubMed
431375812A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system.Nat Biotechnol2019https://conductscience.org/library/papers/31375812PubMed
523918283The lysosome: from waste bag to potential therapeutic target.J Mol Cell Biol2013https://conductscience.org/library/papers/23918283PubMed
630508662Therapeutic strategies for prion disease: a practical perspective.Curr Opin Pharmacol2019https://conductscience.org/library/papers/30508662PubMed
721278748Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.Nat Med2011https://conductscience.org/library/papers/21278748PubMed
834324063Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.Acta Neuropathol2021https://conductscience.org/library/papers/34324063PubMed
99115264
2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells.
J Biol Chem1997https://conductscience.org/library/papers/9115264PubMed
1031329627PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment.PLoS One2019https://conductscience.org/library/papers/31329627PubMed
1119887900De novo mammalian prion synthesis.Prion2009https://conductscience.org/library/papers/19887900PubMed
1232184948New Chemical Modalities and Strategic Thinking in Early Drug Discovery.ACS Med Chem Lett2020https://conductscience.org/library/papers/32184948PubMed
1327124551From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?J Med Chem2016https://conductscience.org/library/papers/27124551PubMed
1427187154AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.J Cell Physiol2016https://conductscience.org/library/papers/27187154PubMed
151353761Evidence for synthesis of scrapie prion proteins in the endocytic pathway.J Biol Chem1992https://conductscience.org/library/papers/1353761PubMed
1628972160An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.J Biol Chem2017https://conductscience.org/library/papers/28972160PubMed
178100741Mice devoid of PrP are resistant to scrapie.Cell1993https://conductscience.org/library/papers/8100741PubMed
1834657408Sporadic Creutzfeldt-Jakob disease: Real-Time Quaking Induced Conversion (RT-QuIC) assay represents a major diagnostic advance.Eur J Histochem2021https://conductscience.org/library/papers/34657408PubMed
199501156The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9501156PubMed
2022956830Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease.J Neurosci2012https://conductscience.org/library/papers/22956830PubMed

See all 95 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41754559Human Prion Disease: Pathogenesis, Diagnosis and Public Health.Viruses2026https://conductscience.org/library/papers/41754559

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41004053

GET https://conductscience.org/api/papers/v1/41004053/references?page=2